Reneo Pharmaceuticals, Inc. (NasdaqGM:RPHM) announces a share repurchase program. Under the program, the company will repurchase up to 576,443 shares, for $4.4 million. The shares will be repurchased from vTv Therapeutics LLC (the ?Selling Stockholder?) at a price of $7.64 per share.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.815 USD | -3.97% | +16.67% | +18.12% |
05-16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
05-13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.12% | 63.17M | |
+44.48% | 55.07B | |
-0.86% | 41.79B | |
+44.19% | 40.22B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. announces an Equity Buyback for 576,443 shares, for $4.4 million.